Randomized Study of ICE Plus RITUXIMAB Versus DHAP Plus Rituximab in Previously Treated Patients With Diffuse Large B-Cell Lymphoma, Followed by Randomized Maintenance With Rituximab
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Rituximab (Primary) ; Carboplatin; Carmustine; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Ifosfamide; Melphalan
- Indications Diffuse large B cell lymphoma
- Focus Registrational; Therapeutic Use
- Acronyms CORAL
- 30 Jan 2014 Accural to date is 100% as per United Kingdom Clinical Research Network record.
- 07 Jun 2011 Final analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 03 Jul 2010 Additional lead trial centre and investigator identified as reported by United Kingdom Clinical Research Network record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History